Similar articles

• Development and characterization of monoclonal antibodies reactive with paraquat.

  Nagao M, Takatori T, Wu B, Terazawa K, Gotouda H, Akabane H. Nagao M, et al. J Immunoassay. 1989;10(1):1-17. doi: 10.1080/01971528908053224. J Immunoassay. 1989. PMID: 2715345
• The development of mouse monoclonal antibodies that bind and neutralize paraquat.

  Wright AF, Green TP, Smith LL. Wright AF, et al. Dev Biol Stand. 1987;66:495-501. Dev Biol Stand. 1987. PMID: 3582772
• Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies.

  Zanella I, Verardi R, Negrini R, Osio L, Albertini A, Ghielmi S. Zanella I, et al. Year Immunol. 1993;7:213-9. Year Immunol. 1993. PMID: 8396821 No abstract available.
• Hybridomas and monoclonal antibodies: applications in oncology.

  Zalcberg JR, McKenzie IF. Zalcberg JR, et al. Aust N Z J Surg. 1982 Aug;52(4):431-8. doi: 10.1111/j.1445-2197.1982.tb06024.x. Aust N Z J Surg. 1982. PMID: 7052043 Review. No abstract available.
• Novel approaches to the preparation and use of monoclonal antibodies.

  Lemieux R, Bazin R. Lemieux R, et al. Transfus Med Rev. 1993 Jan;7(1):25-36. doi: 10.1016/s0887-7963(93)70030-9. Transfus Med Rev. 1993. PMID: 8381687 Review. No abstract available.